Brief: HLB Acquires Shares Worth 10 Mln Dollars In LSK Biopartners In U.S.
30/04/2019 08:43
April 30 (Reuters) - HLB Inc 028300.KQ :
* SAYS ACQUIRES SHARES WORTH 10 MILLION DOLLARS IN LSK
BIOPARTNERS
IN U.S.
Source text for Eikon: https://tinyurl.com/y53n8kyl
Further company coverage: 028300.KQ
((Reuters Messaging: yuna.park.thomsonreuters.com@reuters.net))
Recent news on HLB
See all newsBrief: Elevar Therapeutics' NDA Resubmission For Rivoceranib With Camrelizumab Accepted By FDA
Brief: Elevar Therapeutics Resubmits NDA To U.S. FDA For Camrelizumab Plus Rivoceranib Astreatment For Unresectable Hepatocellular Carcinoma
Brief: Hlb Inc To Acquire 16 Billion Won Worth Of Shares In Neurotobe Pharmaceuticals Inc
Health Rounds: Exercise helps with sexual dysfunction after prostate cancer treatment
Brief: HLB Inc Signs 18.5 Billion Won Supply Deal